NDC 76310-024-15 - Foscavir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76310-024
- Requested NDC
- 76310-024-15
- Package NDCs from labels
- 76310-024-15, 76310-024-25, 76310-024-11, 76310-024-01, 76310-024-41, 76310-024-45
- Manufacturer
- Clinigen Limited
- Effective date
- 2025-12-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Foscavir - Clinigen Limited | Clinigen Limited | 2025-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Foscavir - Clinigen Limited | Clinigen Limited | 2025-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Foscavir - Clinigen Limited | Clinigen Limited | 2023-11-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76310-024-15 | Foscavir | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 22 | |
| 76310-024-15 | Foscavir | 250 mL in 1 BOTTLE | INJECTION, SOLUTION | 250 | 22 | |
| 76310-024-25 | Foscavir | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 22 | |
| 76310-024-01 | Foscavir | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 16 | |
| 76310-024-11 | Foscavir | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 16 | |
| 76310-024-11 | Foscavir | 250 mL in 1 BOTTLE | INJECTION, SOLUTION | 250 | 16 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76310-024 | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN LIMITED] | 21 | Current NDC, Legacy NDC, 3 package rows | 20241122_a09299d5-9c55-4cef-aed0-3a6a45532289.zip |
| 76310-024 | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN LIMITED] | 15 | Current NDC, Legacy NDC, 3 package rows | 20241122_90e3da4e-3b1f-428b-99ca-e4bed1c80028.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76310-024-01 | ML - Milliliter | 76310-024 | d42ef6be-3360-41b4-979d-2ed71db24493 | 1 | 2015-03-03 |
| 76310-024-11 | ML - Milliliter | 76310-024 | e864fc20-812d-4db6-bf3d-ae61ddc14434 | 1 | 2019-05-02 |
| 76310-024-15 | ML - Milliliter | 76310-024 | c6522f73-3765-465b-8ae0-02b16a63fe2c | 1 | 2018-08-13 |
| 76310-024-25 | ML - Milliliter | 76310-024 | 97ab2e67-b14b-45cf-9c0f-a1eb895f75aa | 1 | 2013-02-13 |
| 76310-024-41 | ML - Milliliter | 76310-024 | 76dcf366-1dee-4a3b-8b56-8b106690bb42 | 1 | 2021-05-05 |
| 76310-024-45 | ML - Milliliter | 76310-024 | f43f7d6d-fa25-4dec-ab95-c3467b5d4590 | 1 | 2021-04-08 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| foscarnet sodium | ACTIVE INGREDIENT | 964YS0OOG1 | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 8 | |
| foscarnet | ACTIVE MOIETY | 364P9RVW4X | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 8 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 8 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 8 | |
| foscarnet sodium | ACTIVE INGREDIENT | 964YS0OOG1 | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 2 | |
| foscarnet | ACTIVE MOIETY | 364P9RVW4X | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 2 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 2 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eye Clean | EYE WASH | HART Health | 41f53e2e-c2bc-4bf1-a541-3bcb2cf63002 | 2025-12-31 | Warnings | 059QF0KO0R |
| teeth and gums | CALC FLUORICA, CALC PHOS, FERRUM PHOS, KALI PHOS, MAG PHOS, MALUS PUMILA, FLOS, ROCK WATER, ULEX EUROPAEUS, FLOS | Siddha Flower Essences LLC | 926c79d5-d270-4c0d-aca9-b58571c24f3a | 2025-12-31 | Warnings | 059QF0KO0R |
| lung and sinus | CALC PHOS, FERRUM PHOS, GENTIANELLA AMARELLA, FLOS, KALI MUR, KALI PHOS, KALI SULPH, ROCK WATER, ROSE CANINA, FLOS | Siddha Flower Essences LLC | 9f7c949f-21bc-473c-ab8d-24837893fccc | 2025-12-31 | Warnings | 059QF0KO0R |
| Quality Choice Eye Wash | WATER | Chain Drug Marketing Assoc., Inc. | 1fb8a109-351b-7039-e063-6394a90a7311 | 2025-12-30 | Warnings | 059QF0KO0R |
| Rite Aid Eye Wash | PURIFIED WATER | Rite Aid | 28a18e04-d735-a511-e063-6394a90af6bb | 2025-12-30 | Warnings | 059QF0KO0R |
| OCUFRESH | WATER | Optics Laboratory Inc. | b8e477a9-66b9-496b-92fb-3d4bbd7b36b5 | 2025-12-29 | Warnings | 059QF0KO0R |
| Kollourion Eyesalve Eyewash | PURIFIED WATER 98.3% | Miracle Eye Pharmaceuticals | b56d2ab9-169b-b490-e053-2a95a90a80b3 | 2025-12-28 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Hemorrhoid | AESCULUS HIPP, HAMAMELIS, ALOE, CALC PHOS, CARBO AN, CARBO VEG, LACHESIS, LYCOPODIUM, MURIATICUM AC, NITRICUM AC, NUX VOM, PAEONIA, RATANHIA, SEPIA, SULPHUR | Natural Creations, Inc | db1b3aef-ba92-417c-b6f6-58e950ed4214 | 2025-12-16 | Warnings | QTT17582CB |
| Foscavir | FOSCARNET SODIUM | Clinigen Limited | a09299d5-9c55-4cef-aed0-3a6a45532289 | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | NDA020068 76310-024-25 76310-024-15 76310-024 76310002415 855613 1734377 6792504c-7fa0-4179-9c76-1f6a2ced2832 a09299d5-9c55-4cef-aed0-3a6a45532289 964YS0OOG1 |
| Foscavir | FOSCARNET SODIUM | Clinigen Limited | 90e3da4e-3b1f-428b-99ca-e4bed1c80028 | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | NDA020068 76310-024-01 76310-024-11 76310-024 855613 1734377 978ea7a4-753f-4a86-ae9d-87cfa1290eb8 90e3da4e-3b1f-428b-99ca-e4bed1c80028 964YS0OOG1 |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.